Patents Assigned to Bespoke Bioscience, LLC
  • Compositions and methods of aloe polysaccharides
    Patent number: 10918659
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: February 16, 2021
    Assignee: Bespoke Bioscience, LLC
    Inventor: Ivan E. Danhof
  • Compositions and methods of Aloe polysaccharides
    Patent number: 10314858
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: June 11, 2019
    Assignee: Bespoke Bioscience, LLC
    Inventor: Ivan E. Danhof
  • Role of N-2-hydroxy-ethyl-piperazine-N?-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury
    Patent number: 10213425
    Abstract: Compositions and therapeutic uses of HEPES and derivatives in the treatment of pain associated with cancers and side-effects including post-chemotherapy cognitive impairment are disclosed herein. HEPES is also used to treat neurodegenerative and neurological diseases, demyelinization injuries, and side-effects and withdrawal symptoms associated with benzodiazepines, anti-depressants, and other neurological agents.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: February 26, 2019
    Assignee: BESPOKE BIOSCIENCE, LLC
    Inventor: Ivan E. Danhof
  • Role of N-2-hydroxy-ethyl-piperazine-N?-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury
    Patent number: 9867820
    Abstract: Compositions and therapeutic uses of HEPES and derivatives in the treatment of pain associated with cancers and side-effects including post-chemotherapy cognitive impairment are disclosed herein. HEPES is also used to treat neurodegenerative and neurological diseases, demyelinization injuries, and side-effects and withdrawal symptoms associated with benzodiazepines, anti-depressants, and other neurological agents.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: January 16, 2018
    Assignee: Bespoke Bioscience, LLC
    Inventor: Ivan E. Danhof
  • Compositions and methods of aloe polysaccharides
    Patent number: 9649326
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: May 16, 2017
    Assignee: Bespoke Bioscience, LLC
    Inventor: Ivan E. Danhof